BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

790 related articles for article (PubMed ID: 4649627)

  • 1. A triple regimen of streptomycin, isoniazid and ethambutol or rifampicin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis. 3.
    Oka S; Sasaki M; Kobayashi T; Matsuda T
    Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):84-8. PubMed ID: 4649627
    [No Abstract]   [Full Text] [Related]  

  • 2. A triple regimen of streptomycin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis. 2.
    Oka S; Kayaba K
    Sci Rep Res Inst Tohoku Univ Med; 1970 Dec; 17(3):106-9. PubMed ID: 5525311
    [No Abstract]   [Full Text] [Related]  

  • 3. Two phase chemotherapy with streptomycin isoniazid and ethambutol, followed by isoniazid and ethambutol.
    Purohit SD; Sharma GS; Bomb BS
    J Assoc Physicians India; 1975 Jun; 23(6):385-9. PubMed ID: 1184566
    [No Abstract]   [Full Text] [Related]  

  • 4. Rifampin in association with isoniazid, streptomycin, and ethambutol, respectively, in the initial treatment of pulmonary tuberculosis.
    Nitti V; Catena E; Delli Veneri F; De Michele G; Marra A
    Am Rev Respir Dis; 1971 Mar; 103(3):329-37. PubMed ID: 5005040
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical effect of rifampicin-ethambutol isoniazid on untreated pulmonary tuberculosis.
    Konno K; Oizumi K; Yamada S; Ogata K; Sato M
    Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):68-72. PubMed ID: 4649624
    [No Abstract]   [Full Text] [Related]  

  • 6. Practical application of short-course (6 month) regimens of chemotherapy for pulmonary tuberculosis in Kenyan nomads.
    Aluoch JA
    East Afr Med J; 1979 Mar; 56(3):121-6. PubMed ID: 487976
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract]   [Full Text] [Related]  

  • 8. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intermittent chemotherapy of pulmonary tuberculosis with rifampicin and ethambutol].
    Virsik K; Kruty R; Matula F; Badalik L
    Probl Tuberk; 1978 Oct; (10):28-30. PubMed ID: 714902
    [No Abstract]   [Full Text] [Related]  

  • 10. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
    Shah AR; Agarwal SK; Shah KV
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association.
    Lancet; 1976 Nov; 2(7995):1102-4. PubMed ID: 62946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled therapeutic trial with the combination rifampicin-isoniazid given for six months to previously untreated patients with pulmonary tuberculosis.
    Dubra F
    Bull Int Union Tuberc; 1972 Feb; 47():37-40. PubMed ID: 4562016
    [No Abstract]   [Full Text] [Related]  

  • 13. [Late results of treatment with rifampicin combined with SM and INH in newly detected cases of pulmonary tuberculosis].
    Szymański A
    Pneumonol Pol; 1976 Mar; 44(3):227-35. PubMed ID: 1257096
    [No Abstract]   [Full Text] [Related]  

  • 14. [Intermittent administration of streptomycin, isoniazid and ethambutol in pulmonary tuberculosis].
    Jesiotr M; Hoffman R; Klima E
    Harefuah; 1971 Jun; 80(12):639-40. PubMed ID: 5156426
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug therapy of tuberculosis in the child].
    Freerksen E
    Monatsschr Kinderheilkd (1902); 1969 Aug; 117(8):513-8. PubMed ID: 4921462
    [No Abstract]   [Full Text] [Related]  

  • 16. [Maximum therapeutic efficiency of a guternary antitubercular preparation. (Streptomycin-ethambutol-rifampicin-isoniazid)].
    Almansa de Cara S
    Rev Clin Esp; 1972 May; 125(4):353-6. PubMed ID: 5080180
    [No Abstract]   [Full Text] [Related]  

  • 17. [A controlled comparison of daily and intermittent triple drug regimens (SM-INH-EB) in original treatment. Report of the 16th series of Controlled Trial of Chemotherapy (author's transl)].
    Kekkaku; 1974 Aug; 49(8):247-52. PubMed ID: 4427402
    [No Abstract]   [Full Text] [Related]  

  • 18. [Complex treatment of patients with destructive pulmonary tuberculosis including intramuscular administration of isoniazid].
    Kalankhodzhaev AA; Gamzaeva NF
    Probl Tuberk; 1991; (5):21-2. PubMed ID: 1924235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
    Zierski M; Bek E
    Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
    [No Abstract]   [Full Text] [Related]  

  • 20. Simplified short-course treatment of pulmonary tuberculosis: experience with a regimen of ethambutol, rifampicin and isoniazid for 2 months followed by isoniazid or rifampicin for 4 months.
    Gonzalez Montaner LJ; Leston JM; Cetrangolo A; Szemzo J; Calvete C; Dambrosi A; Mosca C
    Bull Int Union Tuberc; 1976; 51(1):87-9. PubMed ID: 1030316
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 40.